CV Information: Supervisions (On-Going PhD.)
SHAZANA HILDA BINTI SHAMSUDDIN DR. SHAZANA HILDA BINTI SHAMSUDDIN
Start Year, Student Name, Category, Mode, Thesis Title, Supervisor Type
1 2026, AHMAD TALHA BIN MOHAMAD YUNUS, PHD, RESEARCH - FULL TIME, Development of in-silico based aptamer diagnostic tools for parathyroid disorder disease detection, CO-SUPERVISOR
2 2026, SHAHIDATUL ADHA BINTI MOHAMAD, PHD, RESEARCH - FULL TIME, Development of DNA-Aptamer-Based Biosensors for Rapid Serum Detection of AQP4-IgG and MOG-IgG in Optic Neuritis, CO-SUPERVISOR
3 2025, AKBAR MD ALI, PHD, RESEARCH - FULL TIME, TNFR2 Aptamer-Functionalized Gold Nanoparticle: Mechanistic Investigation of Regulatory T-cell for Tumour Immunotherapy, CO-SUPERVISOR
4 2025, SHANNEN WONG QI - E, PHD, RESEARCH - FULL TIME, Investigating the Therapeutic Potential of Trehalulose-Preconditioned Neural Stem Cells for Ischemic Stroke Using an Aptamer-Based Analytical Tools, CO-SUPERVISOR
5 2025, HU XIAORUI, PHD, RESEARCH - FULL TIME, Development of Alginate-Agarose Hydrogels Integrated Aptamer for Keloid Fibrosis Suppression Development, CO-SUPERVISOR
6 2025, WONG JIA YING, PHD, RESEARCH - FULL TIME, Development of Electrochemical Aptamagneto Biosensor for Rapid Detection of Pathogenic Leptospira, CO-SUPERVISOR
7 2024, NURFATIHAH AZLYNA BINTI AHMAD SUHAIMI, PHD, RESEARCH - FULL TIME, Development of Standardized Honey for Depression Via Propolis Pot Manipulation, CO-SUPERVISOR
8 2023, DIVEYAA SIVAKUMAR, PHD, RESEARCH - FULL TIME, GABA, CO-SUPERVISOR
9 2023, YUSUF LUKMAN, PHD, RESEARCH - FULL TIME, Development of DNA Aptamer as a Synthetic Bioreceptor and Biosensor for Cervical Cancer Detection, MAIN SUPERVISOR
10 2022, SADIA FARHANA, PHD, RESEARCH - FULL TIME, Explicating Cryopreserved Adipose Tissue and Adipose-Derived Stem Cells as Therapeutic Agents for Wound Healing in In Vivo and Ex Vivo Models, CO-SUPERVISOR
11 2022, MISHAAL ELBASHEER BABIKER ELMAHI, PHD, RESEARCH - PART TIME, Evaluation of DNA Aptamer as Alternative Synthetic Bioreceptor for HER4 Detection in Triple Negative Breast Cancer, CO-SUPERVISOR